RIM
MEDP icon

Ranger Investment Management’s Medpace MEDP Stock Holding History

Ranger Investment Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.2M Sell
48,357
-360
-0.7% -$184K 1.68% 20
2025
Q4 		$27.4M Sell
48,717
-158
-0.3% -$89.7K 1.88% 16
2025
Q3 		$25.1M Sell
48,875
-18,872
-28% -$8.24M 1.75% 24
2025
Q2 		$21.3M Sell
67,747
-3,665
-5% -$1.1M 1.48% 30
2025
Q1 		$21.8M Sell
71,412
-1,064
-1% -$358K 1.56% 27
2024
Q4 		$24.1M Sell
72,476
-1,595
-2% -$541K 1.52% 28
2024
Q3 		$24.7M Sell
74,071
-44,312
-37% -$16.8M 1.59% 31
2024
Q2 		$48.8M Sell
118,383
-1,530
-1% -$606K 3.32% 4
2024
Q1 		$48.5M Sell
119,913
-18,831
-14% -$6.62M 3.12% 3
2023
Q4 		$42.5M Sell
138,744
-50,958
-27% -$13.8M 2.58% 6
2023
Q3 		$45.9M Sell
189,702
-6,926
-4% -$1.77M 3.05% 5
2023
Q2 		$47.2M Buy
196,628
+5,960
+3% +$1.24M 2.84% 6
2023
Q1 		$35.9M Buy
190,668
+11,265
+6% +$2.33M 2.4% 15
2022
Q4 		$38.1M Sell
179,403
-22,608
-11% -$4.52M 2.83% 8
2022
Q3 		$31.8M Sell
202,011
-108,721
-35% -$17.3M 2.49% 13
2022
Q2 		$46.5M Sell
310,732
-6,170
-2% -$893K 3.52% 5
2022
Q1 		$51.8M Buy
316,902
+8,200
+3% +$1.35M 3.28% 3
2021
Q4 		$67.2M Sell
308,702
-22,271
-7% -$4.66M 3.67% 3
2021
Q3 		$62.6M Sell
330,973
-8,955
-3% -$1.63M 3.34% 3
2021
Q2 		$60M Sell
339,928
-7,936
-2% -$1.37M 3.13% 3
2021
Q1 		$57.1M Sell
347,864
-36,638
-10% -$5.6M 3.14% 4
2020
Q4 		$53.5M Sell
384,502
-12,951
-3% -$1.63M 2.82% 6
2020
Q3 		$44.4M Sell
397,453
-2,810
-0.7% -$325K 2.83% 9
2020
Q2 		$37.2M Sell
400,263
-35,893
-8% -$3.05M 2.55% 13
2020
Q1 		$32M Buy
436,156
+103,591
+31% +$8.99M 2.82% 8
2019
Q4 		$28M Buy
332,565
+94,274
+40% +$7.3M 1.84% 24
2019
Q3 		$20M Sell
238,291
-104,104
-30% -$7.87M 1.44% 36
2019
Q2 		$22.4M Sell
342,395
-3,220
-0.9% -$186K 1.53% 29
2019
Q1 		$20.4M Buy
345,615
+136,026
+65% +$8.13M 1.47% 33
2018
Q4 		$11.1M Buy
+209,589
New +$11.5M 0.9% 44

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Ranger Investment Management's MEDP Position: Q1 2026 in Review

Ranger Investment Management reduced its Medpace (MEDP) stake by 0.74% in Q1 2026, selling an estimated $184K and leaving 48,357 shares worth $23.2M. The position accounts for 1.68% of the portfolio, ranked #20.

Ranger Investment Management first reported a position in MEDP in Q4 2018 and has held it in 30 quarters since. The position peaked at $67.2M in Q4 2021. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Ranger Investment Management held 48,357 shares of Medpace worth $23.2M as of Q1 2026.
  • Ranger Investment Management sold 360 Medpace shares in Q1 2026, an estimated $184K.
  • Medpace made up 1.68% of Ranger Investment Management's portfolio in Q1 2026, its #20 holding.
  • Ranger Investment Management first reported a position in Medpace in Q4 2018 and has held it in 30 quarters since.
  • Ranger Investment Management's Medpace position peaked at $67.2M in Q4 2021.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Ranger Investment Management's 13F filing for Q1 2026, filed 15 May 2026.